FDA declines to scrutinize claims by “low risk” mhealth apps, devices. What’s the takeaway? | Pharma Hub | Scoop.it

FDA said it will ease up vetting general health and wellness apps, but it will scrutinize clinical applications and devices. Does this mean the FTC will step up?

 

 

 


Via rob halkes